BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6203280)

  • 1. Assessment of atrophy of human skin caused by corticosteroids using chamber occlusion and suction blister techniques.
    Somerma S; Lassus A; Salde L
    Acta Derm Venereol; 1984; 64(1):41-5. PubMed ID: 6203280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
    Smith JG; Wehr RF; Chalker DK
    Arch Dermatol; 1976 Aug; 112(8):1115-7. PubMed ID: 952530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development and regression of dermal corticosteroid atrophy. 1. Change in the skinfold thickness].
    Lubach D; Hinz E
    Derm Beruf Umwelt; 1986; 34(5):146-9. PubMed ID: 2947794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin blister and skin biopsy to quantify epidermal nerves: a comparative study.
    Panoutsopoulou IG; Wendelschafer-Crabb G; Hodges JS; Kennedy WR
    Neurology; 2009 Apr; 72(14):1205-10. PubMed ID: 19092108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Duhring chamber assay for corticosteroid atrophy.
    Frosch PJ; Behrenbeck EM; Frosch K; Macher E
    Br J Dermatol; 1981 Jan; 104(1):57-65. PubMed ID: 7459270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous mast cell depletion results from topical corticosteroid usage.
    Lavker RM; Schechter NM
    J Immunol; 1985 Oct; 135(4):2368-73. PubMed ID: 4031494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contact allergy to local steroids. Contact allergy to corticosteroids among consecutively tested patients with eczema].
    Vestergaard L; Andersen KE
    Ugeskr Laeger; 1997 Sep; 159(38):5662-6. PubMed ID: 9340873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of cytokine expression and Langerhans cell migration in human skin following suction blister formation.
    Dearman RJ; Bhushan M; Cumberbatch M; Kimber I; Griffiths CE
    Exp Dermatol; 2004 Jul; 13(7):452-60. PubMed ID: 15217366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multitechnique evaluation of topical corticosteroid treatment.
    Josse G; Rouvrais C; Mas A; Haftek M; Delalleau A; Ferraq Y; Ossant F; George J; Lagarde JM; Schmitt AM
    Skin Res Technol; 2009 Feb; 15(1):35-9. PubMed ID: 19152576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
    Cossmann M; Welzel J
    Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alclometasone dipropionate 0.05% vs hydrocortisone 1.0%: potential to induce cutaneous atrophy in children.
    Kuokkanen K; Sillantaka I
    Clin Ther; 1987; 9(2):223-31. PubMed ID: 3568065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse effects after local application of corticosteroids].
    Thune PO
    Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1202-3. PubMed ID: 4276071
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous suction blister grafting for chronic leg ulcers.
    Costanzo U; Streit M; Braathen LR
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):7-10. PubMed ID: 18181967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment.
    Ahn SK; Bak HN; Park BD; Kim YH; Youm JK; Choi EH; Hong SP; Lee SH
    J Dermatol; 2006 Feb; 33(2):80-90. PubMed ID: 16556273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of topical corticosteroid therapy.
    Baer RL; Myrow R
    Arch Belg Dermatol Syphiligr; 1970; 26(2):129-44. PubMed ID: 4252344
    [No Abstract]   [Full Text] [Related]  

  • 18. Corticosteroid-induced atrophy of the skin with telangiectasia. A clinical and experimental study.
    Stevanović DV
    Br J Dermatol; 1972 Dec; 87(6):548-56. PubMed ID: 4648801
    [No Abstract]   [Full Text] [Related]  

  • 19. A suction blister method that gives epidermal biopsies from mice of different ages, suitable for histologic studies of Langerhans cells.
    Langkjer ST; Villadsen JH; Bjerring P; Ebbesen P
    Compr Gerontol A; 1987 Jun; 1(2):75-7. PubMed ID: 2455598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid-induced dermal atrophy. Investigations on discontinuous application.
    Lubach D; Bensmann A; Bornemann U
    Dermatologica; 1989; 179(2):67-72. PubMed ID: 2529150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.